Atlas Trials

Adjuvant Anti-Recurrence Treatment With Rapamycin on Early-stage HCC

Clinical trial NCT02724332 · COMPLETED

Trial details

NCT number
NCT02724332
Sponsor
Eastern Hepatobiliary Surgery Hospital
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatocellular CarcinomaRapamycin
Start date
2012-11-01
Primary completion
2015-06-01
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.